Covid-19 Vaccine: FDA Lifts Hold on Covaxin's Clinical Trials in US WHO had earlier suspended the supply of Covaxin through US procurement agencies, after its inspectors identified GMP (good manufacturing practice) deficiencies in the Bharat Biotech's manufacturing plants
